Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology,
Journal Year:
2024,
Volume and Issue:
16(5)
Published: Sept. 1, 2024
Abstract
Polymeric
nanoparticles
(NPs),
specifically
those
comprised
of
biodegradable
and
biocompatible
polyesters,
have
been
heralded
as
a
game‐changing
drug
delivery
platform.
In
fact,
poly(α‐hydroxy
acids)
such
polylactide
(PLA),
poly(lactide‐
co
‐glycolide)
(PLGA),
poly(ε‐caprolactone)
(PCL)
heavily
researched
in
the
past
three
decades
material
basis
polymeric
NPs
for
applications.
As
materials,
these
polymers
found
success
resorbable
sutures,
implants,
even
monolithic,
platforms
sustained
release
therapeutics
(e.g.,
proteins
small
molecules)
diagnostics.
Few
fields
gained
more
attention
through
than
cancer
therapy.
However,
clinical
translational
nanomedicines
treating
solid
tumors
has
not
congruent
with
fervor
or
funding
this
particular
field
research.
Here,
we
attempt
to
provide
comprehensive
snapshot
polyester
context
chemotherapeutic
delivery.
This
includes
preliminary
exploration
nanomedicine
research
space.
We
examine
various
processes
producing
NPs,
including
methods
surface‐functionalization,
related
challenges.
After
detailed
overview
multiple
factors
involved
tumors,
crosstalk
between
particle
design
interactions
biological
systems
is
discussed.
Finally,
report
state‐of‐the‐art
approaches
toward
effective
aiming
at
identifying
new
areas
re‐evaluating
reasons
why
some
avenues
underdelivered.
hope
our
effort
will
contribute
better
understanding
gap
fill
delineate
future
work
needed
bring
polyester‐based
closer
application.
article
categorized
under:
Therapeutic
Approaches
Drug
Discovery
>
Nanomedicine
Oncologic
Disease
Nanotechnology
Biology
Nanoscale
Systems
Emerging
Technologies
Chem & Bio Engineering,
Journal Year:
2024,
Volume and Issue:
1(9), P. 757 - 772
Published: Oct. 3, 2024
Nanoparticles
entering
biological
systems
or
fluids
inevitably
adsorb
biomolecules,
such
as
protein,
on
their
surfaces,
forming
a
protein
corona.
Ensuing,
the
corona
endows
nanoparticles
with
new
identity
and
impacts
interaction
between
systems.
Hence,
development
of
reliable
techniques
for
isolation
analysis
is
key
understanding
behaviors
nanoparticles.
First,
this
review
systematically
outlines
approach
isolating
corona,
including
centrifugation,
magnetic
separation,
size
exclusion
chromatography,
flow-field-flow
fractionation,
other
emerging
methods.
Next,
we
qualitative
quantitative
characterization
methods
Finally,
underscore
necessary
steps
to
advance
efficiency
fidelity
nanoparticle
surfaces.
We
anticipate
that
these
insights
into
methodologies
will
profoundly
influence
technologies
aimed
at
elucidating
bionano
interactions
role
in
various
biomedical
applications.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: March 8, 2024
The
protein
corona,
a
dynamic
biomolecular
layer
that
forms
on
nanoparticle
(NP)
surfaces
upon
exposure
to
biological
fluids
is
emerging
as
valuable
diagnostic
tool
for
improving
plasma
proteome
coverage
analyzed
by
liquid
chromatography-mass
spectrometry
(LC-MS/MS).
Here,
we
show
spiking
small
molecules,
including
metabolites,
lipids,
vitamins,
and
nutrients
(namely,
glucose,
triglyceride,
diglycerol,
phosphatidylcholine,
phosphatidylethanolamine,
L-α-phosphatidylinositol,
inosine
5′-monophosphate,
B
complex),
into
can
induce
diverse
corona
patterns
otherwise
identical
NPs,
significantly
enhancing
the
depth
of
profiling.
coronas
polystyrene
NPs
when
exposed
treated
with
an
array
molecules
(n=10)
allowed
detection
1793
proteins
marking
8.25-fold
increase
in
number
quantified
compared
alone
(218
proteins)
2.63-fold
relative
untreated
(681
proteins).
Furthermore,
discovered
adding
1000
µg/ml
phosphatidylcholine
could
singularly
enable
897
proteins.
At
this
specific
concentration,
selectively
depleted
four
most
abundant
proteins,
albumin,
thus
reducing
range
enabling
lower
abundance.
By
employing
optimized
data-independent
acquisition
(DIA)
approach,
inclusion
led
1436
single
sample.
Our
molecular
results
revealed
interacts
albumin
via
hydrophobic
interactions,
h-bonds,
water-bridges.
Addition
also
enabled
337
additional
proteoforms
using
top-down
proteomics
approach.
These
significant
achievements
are
made
utilizing
only
NP
type
one
molecule
analyze
sample,
setting
new
standard
Given
critical
role
biomarker
discovery
disease
monitoring,
anticipate
widespread
adoption
methodology
identification
clinical
translation
proteomic
biomarkers
FDA
approved
diagnostics.
Langmuir,
Journal Year:
2024,
Volume and Issue:
40(15), P. 7781 - 7790
Published: April 4, 2024
The
distinct
features
of
nanoparticles
have
provided
a
vast
opportunity
developing
new
diagnosis
and
therapy
strategies
for
miscellaneous
diseases.
Although
few
nanomedicines
are
available
in
the
market
or
translation
stage,
many
important
issues
still
unsolved.
When
entering
body,
nanomaterials
will
be
quickly
coated
by
proteins
from
their
surroundings,
forming
corona
on
surface,
so-called
protein
corona.
Studies
shown
that
has
biological
implications,
particularly
at
vivo
level.
For
example,
they
can
promote
immune
system
to
rapidly
clear
these
outer
materials
prevent
playing
designed
role
therapy.
In
this
Perspective,
techniques
characterizing
protein–nanoparticle
interactions
critically
summarized.
Effects
nanoparticle
properties
environmental
factors
formation,
which
further
regulate
fate
nanoparticles,
highlighted
discussed.
Moreover,
recent
progress
biomedical
application
corona-engineered
is
introduced,
future
directions
yet
challenging
research
area
also
briefly
Langmuir,
Journal Year:
2024,
Volume and Issue:
40(29), P. 15205 - 15213
Published: July 11, 2024
The
size
or
the
curvature
of
nanoparticles
(NPs)
plays
an
important
role
in
regulating
composition
protein
corona.
However,
molecular
mechanisms
how
affects
interaction
NPs
with
serum
proteins
still
remain
elusive.
In
this
study,
we
employ
all-atom
dynamics
simulations
to
investigate
interactions
between
two
typical
and
PEGylated
Au
three
different
surface
curvatures
(0,
0.1,
0.5
nm
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology,
Journal Year:
2024,
Volume and Issue:
16(5)
Published: Sept. 1, 2024
Abstract
Polymeric
nanoparticles
(NPs),
specifically
those
comprised
of
biodegradable
and
biocompatible
polyesters,
have
been
heralded
as
a
game‐changing
drug
delivery
platform.
In
fact,
poly(α‐hydroxy
acids)
such
polylactide
(PLA),
poly(lactide‐
co
‐glycolide)
(PLGA),
poly(ε‐caprolactone)
(PCL)
heavily
researched
in
the
past
three
decades
material
basis
polymeric
NPs
for
applications.
As
materials,
these
polymers
found
success
resorbable
sutures,
implants,
even
monolithic,
platforms
sustained
release
therapeutics
(e.g.,
proteins
small
molecules)
diagnostics.
Few
fields
gained
more
attention
through
than
cancer
therapy.
However,
clinical
translational
nanomedicines
treating
solid
tumors
has
not
congruent
with
fervor
or
funding
this
particular
field
research.
Here,
we
attempt
to
provide
comprehensive
snapshot
polyester
context
chemotherapeutic
delivery.
This
includes
preliminary
exploration
nanomedicine
research
space.
We
examine
various
processes
producing
NPs,
including
methods
surface‐functionalization,
related
challenges.
After
detailed
overview
multiple
factors
involved
tumors,
crosstalk
between
particle
design
interactions
biological
systems
is
discussed.
Finally,
report
state‐of‐the‐art
approaches
toward
effective
aiming
at
identifying
new
areas
re‐evaluating
reasons
why
some
avenues
underdelivered.
hope
our
effort
will
contribute
better
understanding
gap
fill
delineate
future
work
needed
bring
polyester‐based
closer
application.
article
categorized
under:
Therapeutic
Approaches
Drug
Discovery
>
Nanomedicine
Oncologic
Disease
Nanotechnology
Biology
Nanoscale
Systems
Emerging
Technologies